dc.creatorSuárez, Eduardo Díaz
dc.date.accessioned2014-07-18T16:46:14Z
dc.date.accessioned2018-07-04T16:51:03Z
dc.date.available2014-07-18T16:46:14Z
dc.date.available2018-07-04T16:51:03Z
dc.date.created2014-07-18T16:46:14Z
dc.date.issued2014-05-21
dc.identifier1st Symposium on Current Topics in Molecular Biophysics, 2014, São Paulo
dc.identifierhttp://www.producao.usp.br/handle/BDPI/45830
dc.identifierhttp://biophysics-saopaulo.org/wp-content/uploads/2014/05/ProgramAbstracts_CurrentTopics.pdf
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1641227
dc.description.abstractRecently, potential applications of Desferrioxamine and other iron chelators have attracted attention for the clinicai management of neurodegenerative diseases. Several studies in the literature indicate that metal imbalance in the brain can be involved in neurodegenerative diseases such as Parkinson and Alzheimer. Many genetic disorders in humans are caused by imbalance of body iron. A strategy is to link the iron chelator to peptides such as TAT or penetratin gain access to iron overloaded sites in the brain. In this case, the study of the structure and binding modes of iron to the chelator system helps to understand their biological mode of action.
dc.languageeng
dc.publisherInstituto de Física da Universidade de São Paulo.
dc.publisherSão Paulo
dc.relation1st Symposium on Current Topics in Molecular Biophysics.
dc.rightsEduardo Díaz Suarez
dc.rightsopenAccess
dc.subjectDesferrioxamine
dc.subjectIron chelators
dc.subjectNeurodegenerative diseases
dc.titlePotential applications of Desferrioxamine and other iron chelators for the clinical management of neurodegenerative diseases.
dc.typeActas de congresos


Este ítem pertenece a la siguiente institución